Denali Advisors’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $819K | Buy |
2,100
+300
| +17% | +$127K | 0.08% | 207 |
|
|
2026
Q1 | $852K | Buy |
1,800
+200
| +13% | +$101K | 0.09% | 196 |
|
|
2025
Q4 | $747K | Sell |
1,600
-200
| -11% | -$92.9K | 0.08% | 213 |
|
|
2025
Q3 | $767K | Buy |
1,800
+500
| +38% | +$194K | 0.09% | 189 |
|
|
2025
Q2 | $498K | Sell |
1,300
-1,200
| -48% | -$432K | 0.05% | 227 |
|
|
2025
Q1 | $864K | Hold |
2,500
| – | – | 0.1% | 186 |
|
|
2024
Q4 | $750K | Buy |
2,500
+1,100
| +79% | +$384K | 0.08% | 198 |
|
|
2024
Q3 | $569K | Sell |
1,400
-500
| -26% | -$183K | 0.06% | 224 |
|
|
2024
Q2 | $610K | Sell |
1,900
-500
| -21% | -$162K | 0.17% | 121 |
|
|
2024
Q1 | $800K | Buy |
2,400
+300
| +14% | +$91.7K | 0.24% | 99 |
|
|
2023
Q4 | $568K | Buy |
2,100
+100
| +5% | +$24.7K | 0.17% | 126 |
|
|
2023
Q3 | $492K | Buy |
2,000
+800
| +67% | +$219K | 0.17% | 141 |
|
|
2023
Q2 | $364K | Buy |
+1,200
| New | +$334K | 0.13% | 173 |
|
|
2022
Q2 | – | Sell |
-1,500
| Closed | -$376K | – | 398 |
|
|
2022
Q1 | $376K | Sell |
1,500
-1,300
| -46% | -$326K | 0.15% | 128 |
|
|
2021
Q4 | $719K | Buy |
2,800
+200
| +8% | +$48.9K | 0.27% | 100 |
|
|
2021
Q3 | $631K | Buy |
2,600
+800
| +44% | +$196K | 0.26% | 102 |
|
|
2021
Q2 | $372K | Sell |
1,800
-7,600
| -81% | -$1.55M | 0.14% | 114 |
|
|
2021
Q1 | $1.77M | Sell |
9,400
-34,700
| -79% | -$6.12M | 0.54% | 63 |
|
|
2020
Q4 | $7.25M | Sell |
44,100
-4,800
| -10% | -$702K | 1.24% | 15 |
|
|
2020
Q3 | $6.1M | Sell |
48,900
-1,700
| -3% | -$210K | 1.21% | 16 |
|
|
2020
Q2 | $4.91M | Sell |
50,600
-33,500
| -40% | -$3.48M | 0.95% | 30 |
|
|
2020
Q1 | $7.56M | Buy |
84,100
+15,900
| +23% | +$2.06M | 1.64% | 13 |
|
|
2019
Q4 | $10.1M | Buy |
68,200
+8,100
| +13% | +$1.09M | 1.43% | 19 |
|
|
2019
Q3 | $7.24M | Sell |
60,100
-24,000
| -29% | -$3.1M | 1.01% | 36 |
|
|
2019
Q2 | $11.4M | Sell |
84,100
-16,500
| -16% | -$2.09M | 1.7% | 21 |
|
|
2019
Q1 | $13.1M | Sell |
100,600
-11,100
| -10% | -$1.49M | 2.1% | 14 |
|
|
2018
Q4 | $13.9M | Buy |
+111,700
| New | +$15M | 2.32% | 11 |
|
|
2015
Q1 | – | Sell |
-30,100
| Closed | -$2.21M | – | 278 |
|
|
2014
Q4 | $2.21M | Sell |
30,100
-28,300
| -48% | -$1.99M | 0.62% | 63 |
|
|
2014
Q3 | $4.12M | Hold |
58,400
| – | – | 1.19% | 31 |
|
|
2014
Q2 | $3.29M | Hold |
58,400
| – | – | 0.9% | 41 |
|
|
2014
Q1 | $3.07M | Sell |
58,400
-35,500
| -38% | -$1.77M | 0.88% | 44 |
|
|
2013
Q4 | $4.48M | Sell |
93,900
-12,000
| -11% | -$555K | 1.41% | 23 |
|
|
2013
Q3 | $4.53M | Hold |
105,900
| – | – | 1.56% | 17 |
|
|
2013
Q2 | $3.82M | Buy |
+105,900
| New | +$4.1M | 1.42% | 21 |
|
Other funds holding HCA
Denali Advisors's HCA Position: Q2 2026 in Review
Denali Advisors increased its HCA Healthcare (HCA) stake by 17% in Q2 2026, buying an estimated $127K and bringing the position to 2,100 shares worth $819K. The position accounts for 0.08% of the portfolio, ranked #207.
Denali Advisors first reported a position in HCA in Q2 2013 and has held it in 34 quarters since. The position peaked at $13.9M in Q4 2018. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.
- Denali Advisors held 2,100 shares of HCA Healthcare worth $819K as of Q2 2026.
- Denali Advisors bought 300 HCA Healthcare shares in Q2 2026, an estimated $127K.
- HCA Healthcare made up 0.08% of Denali Advisors's portfolio in Q2 2026, its #207 holding.
- Denali Advisors first reported a position in HCA Healthcare in Q2 2013 and has held it in 34 quarters since.
- Denali Advisors's HCA Healthcare position peaked at $13.9M in Q4 2018.
- 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.
Based on Denali Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.